Search Tag: Oxford Biomedics

Executive Health Management

Grand Plans for Potential COVID-19 Vaccine Production

2020 08 Jun

UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners.   You might also like: EU Supports Clinical Trials During COVID-19   The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed... Read more